Sleep Number's shares plunged 27.8% following the earnings release, reflecting investor disappointment primarily with cautious outlook commentary and margin pressures despite early signs of demand improvement. The cautious tone on the turnaround timeline and ongoing capital structure concerns outweighed any operational positives.

• Net sales reached $319 million, roughly in line with expectations, but with a majority of new product sales deferred to Q2 due to late-quarter launches.
• Adjusted EBITDA of $6 million slightly exceeded the company’s internal plan but remains modest relative to scale.
• Early product resets and new launches show promising signs: stores with the new lineup saw a 12% higher average revenue unit (ARU) and ComfortMode product reduces return rates by 100 bps compared to legacy products.
• Management emphasized ongoing macroeconomic headwinds, the need for cautious planning, and incremental near-term liquidity support through an additional $55 million in funding.
• Despite product and marketing initiatives, investors remain concerned about overall margin pressures, capital structure risks, and the uncertain pace of sustainable recovery.